CABR · Caring Brands, Inc. · Metrics
Market Cap
$8.34M
Shares
10.37M
Volume · Nov 12
104.51K
Avg daily vol (3M)
68.25K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CABR metrics
66 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$0.80
Market cap
$8.34M
Price action
23 metricsPrice change (1W)
-4.3%
Price change (30D)
-35.8%
Price change (3M)
-38.1%
Price change (6M)
-18.8%
Price change (YTD)
+0.3%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$1.61
52-week low
$0.75
Change from 52-week high
-46.5%
Change from 52-week low
+15.6%
Annualized volatility
128.6%
Annualized volatility (3M)
129.0%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.0
RSI (14D)
40.6
Price vs SMA 50
-26.1%
Price vs SMA 200
-24.9%
Avg volume (3M)
67,380
Relative volume
1.8
Average dollar volume
$75,886
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
10.37M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1,612.2×
reciprocal yield 0.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
2,117.7×
reciprocal yield 0.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-86.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
55.6%
Operating margin
-140,807.2%
Trailing 12 months
Net margin
-148,948.8%
Gross profit (TTM)
$2,342
Operating profit (TTM)
−$7.10M
Net income (TTM)
−$7.73M
Trailing 12 months
Diluted EPS (TTM)
$-0.74
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-9.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4,215
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-32.6%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-404.6%
Debt / equity
0.0
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.9
Interest coverage
-23.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.13M
Latest balance sheet
Cash & equivalents
$1.82M
Total assets
$1.91M
Total debt
$58,650
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$2.26M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$210,927
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
10
13F filer change QoQ
+4
Institutional ownership
1.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
0.6%
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
-17.4%
Holder tenure
1.8
Price vs estimated holder cost
+17.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.7%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
49 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—